- Home
- EVER vs GHRS Comparison
EVER vs GHRS Comparison
Compare EVER & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVER
- GHRS
- Stock Information
- Founded
- EVER 2008
- GHRS 2018
- Country
- EVER United States
- GHRS Ireland
- Employees
- EVER N/A
- GHRS N/A
- Industry
- EVER Computer Software: Programming Data Processing
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- EVER Technology
- GHRS Health Care
- Exchange
- EVER Nasdaq
- GHRS Nasdaq
- Market Cap
- EVER 960.3M
- GHRS 868.7M
- IPO Year
- EVER 2018
- GHRS 2021
- Fundamental
- Price
- EVER $29.94
- GHRS $12.57
- Analyst Decision
- EVER Strong Buy
- GHRS Strong Buy
- Analyst Count
- EVER 6
- GHRS 7
- Target Price
- EVER $32.33
- GHRS $30.86
- AVG Volume (30 Days)
- EVER 743.4K
- GHRS 264.8K
- Earning Date
- EVER 05-05-2025
- GHRS 05-02-2025
- Dividend Yield
- EVER N/A
- GHRS N/A
- EPS Growth
- EVER N/A
- GHRS N/A
- EPS
- EVER 0.88
- GHRS N/A
- Revenue
- EVER $500,190,000.00
- GHRS N/A
- Revenue This Year
- EVER $26.54
- GHRS N/A
- Revenue Next Year
- EVER $12.65
- GHRS N/A
- P/E Ratio
- EVER $33.81
- GHRS N/A
- Revenue Growth
- EVER 73.72
- GHRS N/A
- 52 Week Low
- EVER $16.63
- GHRS $6.00
- 52 Week High
- EVER $30.02
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- EVER 67.89
- GHRS 61.33
- Support Level
- EVER $25.38
- GHRS $10.20
- Resistance Level
- EVER $29.97
- GHRS $11.75
- Average True Range (ATR)
- EVER 1.63
- GHRS 0.91
- MACD
- EVER 0.17
- GHRS 0.23
- Stochastic Oscillator
- EVER 92.18
- GHRS 93.57
About EVER EverQuote Inc.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.